DERMATOPROTECTIVE ACTIVITY OF A COMBINATION OF ENOXIFOL WITH REXOD IN A REDUCED FORM THE BLOOD CIRCULATION IN THE SKIN IN DIABETES MELLITUS AND HYPERCHOLESTERINEMIA

Experiments in rats showed that the 9-diethylaminoethyl-2-(3,4-dioxyphenyl)-imidazo-[1,2-a]-benzimidazole dihydrobromide with the provisional name of enoxifol (0.94 – 15 mg/kg), rexod (recombinant human superoxide dismutase; 0.002 mg/kg) and especially their combination in intravenous administration...

Full description

Bibliographic Details
Main Authors: Valeria Seletskaya, Pavel Galenko-Yaroshevsky
Format: Article
Language:English
Published: Belgorod National Research University 2017-03-01
Series:Research Results in Pharmacology
Subjects:
Online Access:https://rrpharmacology.pensoft.net/article/31047/download/pdf/